Lakewood-Amedex Biotherapeutics
LABT----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Lakewood-Amedex Biotherapeutics(LABT) the EBIT is -886.75 K (-63.42%);the EPS is -2.02 (-36.13%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B63.42%
----
----
EPS
-2.024936.13%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf